Abbott Laboratories (Pakistan) Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was PKR 13,437.26 million compared to PKR 12,909.27 million a year ago. Revenue was PKR 13,437.26 million compared to PKR 12,909.27 million a year ago. Net loss was PKR 579.85 million compared to net income of PKR 338.23 million a year ago. Basic loss per share from continuing operations was PKR 5.93 compared to basic earnings per share from continuing operations of PKR 3.45 a year ago.
For the six months, sales was PKR 27,243.18 million compared to PKR 24,680.43 million a year ago. Revenue was PKR 27,243.18 million compared to PKR 24,680.43 million a year ago. Net loss was PKR 799.37 million compared to net income of PKR 1,780.01 million a year ago. Basic loss per share from continuing operations was PKR 8.17 compared to basic earnings per share from continuing operations of PKR 18.18 a year ago.